Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

7 Retail Stocks That You Don’t Want In Your Cart

The economy is booming, but that doesn't mean you can expect retail stocks to take off. Some of them are running into some challenges.

QuantumScape Won’t Benefit From the Short Squeeze Traders Are Waiting For

QS stock is heavily shorted and traders are hoping for a squeeze. That may well happen, but the company's long-term outlook is cloudy.

Microvision Is Ripe For Profit-Taking, so Don’t Miss Out

MVIS stock quickly became a Reddit darling due to a short-interest ratio. However, now is the right time to take some money off the table.

Rocket Companies Stock Has Two Risks You Definitely Need to Consider

Keep these two risks in mind when investing in Rocket Companies. It could have an impact on RKT stock in the near term.

Royal Caribbean Is Not a Buy, It’s a Financial Petri Dish

Cruise lines are struggling to get back on the water, but Royal Caribbean's pandemic debt may be too hard to pay. Avoid RCL stock.

Hype or No Hype, Lucid Motors Can’t Evade These Ugly Truths

CCIV stock has been gaining ground lately. But despite the near-term hoopla around Lucid as a “Tesla killer,” it's bound for disappointment.

Canoo Is Paddling Upstream And Shows No Signs Of Changing Course

GOEV stock has cooled and faded in 2021 and there's plenty of reason to believe it'll fall further moving forward.

Naked Brand Is Overvalued Given Its Cash and Rump Value

Naked Brand stock is currently overvalued. NAKD stock is worth just 44 cents, including its cash and rump value based on estimated sales.

Biogen Gets an Unearned Rip on an Unproven Drug

Critics charge the FDA has been compromised and approved Biogen's Alzheimer's drug before it is proven to work.

Castor Maritime’s Profit Doesn’t Make Its Stock a Buy

Castor Maritime delivered a Q1 profit of $1.1 million. Is that enough to make me change my mind about CTRM stock? Not by a longshot. 

Workhorse Is Now Solely in the Hands of the Speculators

WKHS stock is up nearly 45% and short interest in the stock remains high. It's the perfect cocktail for a short squeeze and a good reason to leave the stock to speculators.

Zoom Fatigue Sets in on Investors Despite Post-Pandemic Innovations

Zoom Video is building a huge business on videoconference and digital communications. The problem is investors now see ZM as a value stock.

AMC’s Stock Sales Are Good for the Company and Bad for Shareholders

AMC is unlikely to become profitable for the foreseeable future, and the "apes" probably won't be able to stop AMC stock from dropping tremendously.

Africa Is Too Big a Risk For Jumia Technologies (And Its Shareholders)

Jumia Technologies is ambitious, but its efforts to dominate the African continent have yet to bare any fruit. Investors of JMIA stock beware.

Don’t Get Involved With the Company in Between; Avoid Churchill Capital Stock

Between the high valuation of CCIV stock and the middle-of-the-pack status of Lucid Motors, the shares are unattractive.

7 Stocks to Avoid Due to Pandemic Worker Shortages

Summer camps face labor shortages this summer. They aren't the only ones. Here are seven companies' stocks to avoid due to the pandemic. 

Tilray Stock Will Keep Disappointing With Poor Numbers and No Catalysts

In the last few months, there was no news bigger than the TLRY-APHA merger. But even after the tie-up, TLRY stock is not a winner.

7 Bubble Stocks To Sell While You Still Can

Like a good gardener, investors should take care to prune their positions in overvalued stocks. Here are seven bubble stocks that look overvalued and ripe for selling.

BlackBerry Stock Was Interesting for a Moment

BB stock recently got hot for the second time in 2021. Retail traders have largely abandoned it, and it's not worth buying now.

QuantumScape Stock Demands Too Great a Leap of Faith From Investors

QS stock has the potential to be a paradigm-shattering investment but the road to success is replete with obstacles.